Chemoinformaics analysis of 4-Cyclopentene-1,3-dione
Molecular Weight | 96.085 | nRot | 0 |
Heavy Atom Molecular Weight | 92.053 | nRig | 7 |
Exact Molecular Weight | 96.0211 | nRing | 1 |
Solubility: LogS | -0.464 | nHRing | 0 |
Solubility: LogP | -0.127 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 11 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 12.6212 |
nHD | 0 | BPOL | 5.74883 |
QED | 0.4 |
Synth | 3.008 |
Natural Product Likeliness | 1.376 |
NR-PPAR-gamma | 0.685 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.002 |
HIA | 0.007 |
CACO-2 | -4.519 |
MDCK | 0.0000347 |
BBB | 0.997 |
PPB | 0.576973 |
VDSS | 0.422 |
FU | 0.602639 |
CYP1A2-inh | 0.041 |
CYP1A2-sub | 0.121 |
CYP2c19-inh | 0.037 |
CYP2c19-sub | 0.309 |
CYP2c9-inh | 0.03 |
CYP2c9-sub | 0.313 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.238 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.281 |
CL | 8.913 |
T12 | 0.892 |
hERG | 0.025 |
Ames | 0.623 |
ROA | 0.807 |
SkinSen | 0.942 |
Carcinogencity | 0.834 |
EI | 0.952 |
Respiratory | 0.961 |
NR-Aromatase | 0.026 |
Antiviral | No |
Prediction | 0.924361 |